Hepatitis C virus-specific markers in pediatric patients with chronic hepatitis C.


Journal

Minerva pediatrics
ISSN: 2724-5780
Titre abrégé: Minerva Pediatr (Torino)
Pays: Italy
ID NLM: 101777303

Informations de publication

Date de publication:
03 Dec 2021
Historique:
entrez: 3 12 2021
pubmed: 4 12 2021
medline: 4 12 2021
Statut: aheadofprint

Résumé

The study aimed to investigate hepatitis C virus (HCV) specific markers in chronically infected children. The main objective was to explore the patterns of marker variability. HCV RNA, core antigen, anti-HCV IgM, and antibodies to individual viral proteins were detected using commercially available assays or experimental ELISA. RNA genotyping and recombination were performed by sequencing. HCV RNA and core antigen were detected in serum samples of all children (n=100). Anti-HCV IgM, anti-NS4AB IgG, and anti-NS5A IgG were revealed less often than antibodies to core and NS3 proteins. To elucidate the cause of this finding, all subjects were divided into 4 groups differing in hepatitis duration. It was anti-NS4AB only whose detection depended on the infection duration. A trend was established that the longer the hepatitis duration, the more frequently anti-HCV IgM was observed. No significant impact of HCV RNA load and NS4A/NS4B amino acid substitutions on anti-NS4AB IgG detection was found. The increase HCV genotype 3 was observed among children infected after 2000. The earliest case of infection caused by HCV intergenotype recombinant RF1_2k/1b was identified in a child vertically infected in 1997. HCV genotypes and subtypes were found to be variable virus specific markers in children infected in 1997-2015. Over the period, there has been a trend to change the dominant HCV subtype and appearance of recombinant RF1_2k/1b in children. Among humoral markers, anti-NS4AB revealing is depended on chronic hepatitis C duration, while for anti-HCV IgM, only a trend was established. The detection of anti-NS4AB can be helpful in assessing the duration of chronic hepatitis C.

Sections du résumé

BACKGROUND BACKGROUND
The study aimed to investigate hepatitis C virus (HCV) specific markers in chronically infected children. The main objective was to explore the patterns of marker variability.
METHODS METHODS
HCV RNA, core antigen, anti-HCV IgM, and antibodies to individual viral proteins were detected using commercially available assays or experimental ELISA. RNA genotyping and recombination were performed by sequencing.
RESULTS RESULTS
HCV RNA and core antigen were detected in serum samples of all children (n=100). Anti-HCV IgM, anti-NS4AB IgG, and anti-NS5A IgG were revealed less often than antibodies to core and NS3 proteins. To elucidate the cause of this finding, all subjects were divided into 4 groups differing in hepatitis duration. It was anti-NS4AB only whose detection depended on the infection duration. A trend was established that the longer the hepatitis duration, the more frequently anti-HCV IgM was observed. No significant impact of HCV RNA load and NS4A/NS4B amino acid substitutions on anti-NS4AB IgG detection was found. The increase HCV genotype 3 was observed among children infected after 2000. The earliest case of infection caused by HCV intergenotype recombinant RF1_2k/1b was identified in a child vertically infected in 1997.
CONCLUSIONS CONCLUSIONS
HCV genotypes and subtypes were found to be variable virus specific markers in children infected in 1997-2015. Over the period, there has been a trend to change the dominant HCV subtype and appearance of recombinant RF1_2k/1b in children. Among humoral markers, anti-NS4AB revealing is depended on chronic hepatitis C duration, while for anti-HCV IgM, only a trend was established. The detection of anti-NS4AB can be helpful in assessing the duration of chronic hepatitis C.

Identifiants

pubmed: 34859647
pii: S2724-5276.21.06564-2
doi: 10.23736/S2724-5276.21.06564-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Lyudmila Nikolaeva (L)

Department of Molecular Virology, Ivanovsky Institute of Virology, Gamaleya National Research Centre of Epidemiology and Microbiology, Ministry of Health, Moscow, Russian Federation - l.i.nikolaeva@mail.ru.

Elena Leybman (E)

Department of Molecular Virology, Ivanovsky Institute of Virology, Gamaleya National Research Centre of Epidemiology and Microbiology, Ministry of Health, Moscow, Russian Federation.
Department of Children's Infectious Diseases, Pirogov Russian National Research Medical University, Ministry of Health, Moscow, Russian Federation.

Evgeniy Samokhvalov (E)

Department of Molecular Virology, Ivanovsky Institute of Virology, Gamaleya National Research Centre of Epidemiology and Microbiology, Ministry of Health, Moscow, Russian Federation.

Karen Kyuregyan (K)

Department of Virology, Russian Medical Academy of Continuing Professional Education, Ministry of Health, Moscow, Russian Federation.

Vera Kichatova (V)

Department of Virology, Russian Medical Academy of Continuing Professional Education, Ministry of Health, Moscow, Russian Federation.

Olga Isaeva (O)

Department of Virology, Russian Medical Academy of Continuing Professional Education, Ministry of Health, Moscow, Russian Federation.

Victor Kuprianov (V)

Department of Molecular Biology of Microorganisms, Skryabin Institute of Bioengineering, Federal Research Centre Fundamentals of Biotechnology, Russian Academy of Sciences, Moscow, Russian Federation.

Classifications MeSH